The Effect of Thyroid Dysfunction
1 other identifier
observational
51
1 country
1
Brief Summary
The aim of this study is to investigate the effect of thyroid dysfunction on pain, symptoms, attitudes, fatigue, foot parameters, muscle strength, and lower extremity performance in women with a menstrual cycle, and to compare these findings with those of healthy controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2026
CompletedFirst Submitted
Initial submission to the registry
April 20, 2026
CompletedFirst Posted
Study publicly available on registry
April 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
CompletedJune 22, 2026
April 1, 2026
3 months
April 20, 2026
June 17, 2026
Conditions
Outcome Measures
Primary Outcomes (6)
Foot Function Index
This is a patient-reported outcome measure based on a patient-centered assessment approach that evaluates foot function from different perspectives. It consists of 23 items divided into three subscales: pain, disability, and activity limitation. For each item, patients are asked to rate their condition on a scale from 0 (no pain or difficulty) to 10 (the most severe pain imaginable or extreme difficulty making the activity impossible to perform). Scores for each subscale are calculated separately, and a total score is also recorded. The scores are transformed to a scale ranging from 0 to 100, where 0 represents the best possible outcome (no pain or difficulty) and 100 represents the worst possible outcome (the most severe pain imaginable or extreme difficulty making the activity impossible to perform).
At baseline (Day 1)
Foot Posture Index-6
The Foot Posture Index (FPI) is an assessment tool used to evaluate foot posture by observing the position of the rearfoot and forefoot across multiple planes. This assessment, which takes approximately 4-5 minutes, was performed bilaterally based on observation and palpation from the posterior, medial, lateral, and anterior aspects of the foot. A total of six parameters were evaluated, including three related to the rearfoot and three related to the forefoot. Each parameter was scored on a scale from -2 to +2, and both the total score and the subscores for the forefoot and rearfoot were recorded. The total score was used for interpretation, where 0 indicates a neutral foot posture, positive values indicate a pronated foot posture, and negative values indicate a supinated foot posture.
At baseline (Day 1)
Sit-to-Stand Test
This test evaluates individuals' lower extremity muscle strength and functional performance. In the starting position, the participant's arms are crossed in front of the torso and their feet are in full contact with the floor. Participants are asked to sit down and stand up as quickly as possible for 30 seconds from a standard chair with back support but no armrests. The total number of sit-to-stand cycles is recorded.
At baseline (Day 1)
Trunk Flexor Endurance Test
The participant lies down with the hips and knees flexed to 90°, arms crossed over the chest at shoulder level, and feet in a fixed position. The test begins when the participant's trunk is moved into a supported sitting position with 60° flexion while maintaining this initial position. The trunk support is removed, and the participant is asked to maintain this position for as long as possible. The test ends when the 60° angle between the floor and the upper trunk changes, and the elapsed time is recorded in seconds.
At baseline (Day 1)
Trunk Lateral Flexor Endurance Test
The participant lies on their non-dominant side on a treatment table with their legs extended. The upper foot is placed in front of the lower foot for support. The upper arm is placed across the chest toward the opposite shoulder. The elbow of the lower arm is positioned in flexion and placed so that support can be obtained from the elbow and forearm. The participant is instructed to lift their hips off the ground to form a straight line with their entire body, using support from their elbows and feet. The test ends when the participant loses the test position, and the duration for which the position was maintained is recorded in seconds. The test is performed bilaterally.
At baseline (Day 1)
Longitudinal Arch Measurement
This method, which describes the position of the navicular tubercle relative to the medial malleolus and the line of the first metatarsophalangeal joint, was first developed by McPoil and colleagues. The grading of pes planus is based on the degree to which the navicular tubercle deviates from the Feiss line and approaches the ground.
At baseline (Day 1)
Secondary Outcomes (5)
Menstrual Symptom Scale
At baseline (Day 1)
Visual Analog Scale
At baseline (Day 1)
Menstrual Attitude Scale
At baseline (Day 1)
Multidimensional Fatigue Inventory-20
At baseline (Day 1)
Time up and go test
At baseline (Day 1)
Study Arms (3)
hypothyroid group
This group includes patients diagnosed with hypothyroidism. Participants will undergo clinical assessments and data collection. No intervention will be applied.
hyperthyroidism group
This group includes patients diagnosed with hyperthyroidism. Participants will undergo clinical assessments and data collection. No intervention will be applied.
healthy group
This group includes healthy patients. Participants will undergo clinical assessments and data collection. No intervention will be applied.
Eligibility Criteria
The study population will consist of menstruating women diagnosed with hypothyroidism or hyperthyroidism who apply to the Endocrinology Outpatient Clinic of Usak Training and Research Hospital, and menstruating women who are companions of patients applying to the same clinic for the healthy control group, who meet the inclusion criteria and agree to participate in the study.
You may qualify if:
- Be between the ages of 18 and 55
- Be female
- Be able to communicate in Turkish
- Be willing to participate in the study
- Have signed the informed consent form
- Have a menstrual cycle
You may not qualify if:
- Diagnosed with severe cognitive impairment or dementia
- Having an active psychiatric diagnosis
- Having undergone any surgery in the past year
- Having any rheumatic, neurological, or cancer-related condition
- Using a walking aid
- Having a cardiopulmonary condition that could cause significant functional limitations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Usak Training and Research Hospital, Endocrinology Outpatient Clinic
Uşak, Turkey (Türkiye)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
April 20, 2026
First Posted
April 27, 2026
Study Start
March 1, 2026
Primary Completion
June 1, 2026
Study Completion
August 1, 2026
Last Updated
June 22, 2026
Record last verified: 2026-04